Validation of a sensitive LC/MS/MS method for the determination of telaprevir and its R-isomer in human plasma.
Validation of a sensitive LC/MS/MS method for the determination of telaprevir and its R-isomer in human plasma.
复制标题
验证用于测定人血浆中特拉匹韦及其 R 异构体的灵敏 LC/MS/MS 方法。
DOI:
10.1002/bmc.3211
复制
发表时间:
2014
期刊:
影响因子:
--
通讯作者:
Kiser,JenniferJ
中科院分区:
文献类型:
--
作者:
Chen,Xinhui;Bushman,LaneR;McAllister,KevinJ;Anderson,PeterL;Kiser,JenniferJ
The purpose of this study was to validate a reversed‐phase high‐performance liquid chromatographic (HPLC), tandem mass spectrometry (MS/MS) assay for the determination of telaprevir and itsR‐diastereomer (VRT‐127394) in acidified and nonacidified human plasma. The chromatographic baseline separation of telaprevir and telaprevir‐Rwas performed on a Waters XBridgeTMBEH Shield C18, 2.1 × 75 mm column with a 2.5 µm particle size, under isocratic conditions consisting of a mobile phase of 50:45:5 water–acetonitrile–isopropanol with 1% ammonia at 0.2 mL/min. This method utilized a stable isotope internal standard with 11 deuterium atoms on the structure of the telaprevir molecule (telaprevir‐d11). An internal standard for the telaprevir‐R(telaprevir‐R‐d11) was also prepared by incubating telaprevir‐d11 in basic solution, which facilitated isomer inter‐conversion. The detection and quantitation of telaprevir, telaprevir‐R, telaprevir‐IS and telaprevir‐R‐IS was achieved by positive ion electrospray (ESI+) MS/MS detection. The assay quantifiable limit was 5.0 ng/mL when 0.100 mL of acidified human plasma was extracted. Accuracy and precision were validated over the calibration range of 5.0–5000 ng/mL. It was demonstrated using patient samples that, contrary to previous recommendations, quantitation of telaprevir does not require acidified plasma. Copyright © 2014 John Wiley & Sons, Ltd.